Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
05/20/1992 | EP0485569A1 Cholesterol esterases with variable substrate specificity |
05/20/1992 | EP0485532A1 Fucosyl transferases involved in adhesion molecule expression |
05/20/1992 | EP0485497A1 Il-2 deletion mutants |
05/20/1992 | EP0485407A1 Proteins with tnf activity |
05/20/1992 | CN1016662B Process for preparation of humic acid-microbial protein feed from weathered coal and its products |
05/19/1992 | US5114922 Animal extracts from leeches |
05/19/1992 | US5114858 Purification of DNA by dissolving in a solvent, plunging and filtration |
05/19/1992 | US5114854 Catheters for puncturing cells |
05/19/1992 | US5114853 Generic engineering |
05/19/1992 | US5114852 Chimeric fused monooxygenase of cytochrome P-450 and NADPH-cytochrome P-450 reductase |
05/19/1992 | US5114849 Protectants for microbial fermentation |
05/19/1992 | US5114846 Culture of streptomyces and selecting the asprogenous colonies |
05/19/1992 | US5114844 Immunoassay with a protein or antibody |
05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
05/19/1992 | CA1301101C Method and device for the carrying out of a microbiological or enzymatic process |
05/19/1992 | CA1301095C Human che type proteins and their production |
05/19/1992 | CA1301094C Bacillus thuringiensis crystal protein gene toxin segment |
05/19/1992 | CA1301060C Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus |
05/14/1992 | WO1992008355A1 Process for preparation of bacterial agricultural products |
05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
05/14/1992 | WO1992007938A1 Cell growth inhibitors |
05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
05/13/1992 | EP0485091A1 Process for the production of analogues of immunomycin |
05/13/1992 | EP0484908A2 Microbiological process for the preparation of hydroxylated Pyrazinederivatives |
05/13/1992 | EP0484452A1 Fibulin |
05/13/1992 | EP0484416A1 Regulation of nerve growth factor synthesis in the central nervous system |
05/12/1992 | US5112858 Antitumor agent |
05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
05/12/1992 | US5112744 Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase |
05/12/1992 | CA1300538C Maintenance of the viability of microorganisms for use in microbial inoculants |
05/12/1992 | CA1300533C Sterol regulatory elements |
05/09/1992 | WO1992008736A1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
05/09/1992 | CA2255396A1 Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism |
05/09/1992 | CA2055125A1 Microbiological process for the production of hydroxylated pyrazine derivatives |
05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
05/06/1992 | EP0484281A2 Cyclosporins |
05/06/1992 | EP0483961A1 Specific binding agents |
05/06/1992 | EP0483797A1 Method for cloning and producing the Nco I restriction endonuclease |
05/06/1992 | EP0483691A2 Xyloseisomerase gene of thermus aquaticus, xyloseisomerase and process for preparation of fructose |
05/06/1992 | EP0483655A2 Culture for saprophytic living mushrooms |
05/06/1992 | EP0483509A1 Synthetic gene coding for human parathyroid hormone |
05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
05/06/1992 | CN1060872A Spheroplast fusions of phaffia rhodozyma cells |
05/05/1992 | US5110980 Separation of poly-β-hydroxyalkanoic acid from microbial biomass |
05/05/1992 | US5110905 Activated Bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene |
05/05/1992 | US5110811 Antibody inhibitors |
05/05/1992 | US5110739 Process for selective fermentation with mutants of Pediococcus halophilus |
05/05/1992 | CA1300060C Method of producing hyaluronic acid |
05/05/1992 | CA1300055C Biocontrol of grey-mold in pome fruits using acremonium breve |
05/05/1992 | CA1300053C Human interleukin-2 polypeptide derivative |
05/05/1992 | CA1300023C Lactobacillus bifidus proliferation promoting composition |
05/02/1992 | WO1992007934A1 Bacterial attenuation method and vaccine |
05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
04/30/1992 | WO1992007079A1 Transformation selection marker system adapted for penicillium |
04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
04/30/1992 | WO1992007064A1 Processing of yeast refuse and resulting product |
04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
04/30/1992 | WO1992006988A1 Method for the production of catalytic rna in bacteria |
04/30/1992 | WO1992006698A1 Process for producing spagyric essences from plants |
04/30/1992 | WO1992004448A3 Human mitochondrial nad(p)+-dependent malate enzyme |
04/30/1992 | WO1992003559A3 Test system for checking the activity of viral proteinases |
04/30/1992 | DE4033996A1 Capsules for normalising intestinal flora - contg. freeze-dried Lactobacillus and Bifidobacterium cultures |
04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
04/30/1992 | CA2071854A1 Method for the production of catalytic rna in bacteria |
04/30/1992 | CA2054128A1 Process for the production of analogues of immunomycin |
04/29/1992 | EP0483115A2 Regulatory region for heterologous gene expression in yeast |
04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
04/29/1992 | EP0482909A2 Process for producing antibiotics |
04/29/1992 | EP0482908A2 Process for producing streptovaricin |
04/29/1992 | EP0482879A2 Protease from Bacillus licheniformis |
04/29/1992 | EP0482844A2 GL-7ACA acylase |
04/29/1992 | EP0482714A1 Increased production of thermus aquaticus DNA polymerase in E. coli |
04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
04/29/1992 | EP0482544A2 Spheroplast fusions of phaffia rhodozyma cells |
04/29/1992 | EP0482543A1 Oasomycine, method of its preparation and its use |
04/29/1992 | EP0482530A2 Composition for the regulation of intestinal flora |
04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
04/29/1992 | EP0482077A1 Method for producing novel polyester biopolymers |
04/29/1992 | EP0482018A1 Toxin uses |
04/29/1992 | EP0482017A1 Acaricidal compositions and process for preparing same |
04/28/1992 | US5109121 Using group 2a salt to precipitate impurity |
04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
04/28/1992 | US5108927 Specimen transport device containing a specimen stabilizing composition |
04/28/1992 | US5108925 Using decarbonxylase enzyme gene |
04/28/1992 | US5108924 Pyrimine-producing bacteria |
04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
04/28/1992 | US5108919 Dna sequences encoding yeast ubiquitin hydrolase |
04/28/1992 | US5108917 Process for the preparation of ibuprofen |
04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
04/28/1992 | CA1299508C Human pancreatic elastase i |
04/28/1992 | CA1299435C Free flowing frozen particulate yeasts and use of these novel yeasts in frozen doughs |
04/27/1992 | WO1992007946A1 Protectants for microbial fermentation |
04/27/1992 | CA2054232A1 Oasomycins, a process for the preparation thereof and the use thereof |
04/27/1992 | CA2052827A1 Increased production of thermus aquaticus dna polymerase in e.coli |